A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma

Lymphoma Clinical Trial

Official title:

A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00266370
• Other study ID #: CL-094-CP-01
• Status: Recruiting
• Phase: N/A
• First received: December 15, 2005
• Last updated: December 16, 2005
• Start date: January 2005
• Est. completion date: December 2009

Study information

• Verified date: December 2005
• Source: National Health Research Institutes, Taiwan
• Contact: Ih-Jen Su, M.D., Ph. D.
• Phone: 886-6-2083422
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

1. To establish a pathology reference laboratory for the consultation on the diagnosis of infectious diseases and lymphoma.

2. To study the specific pathogens on 100 cases of unexplained death due to infectious diseases in the files of Taiwan CDC and the Forensic Institutes of Department of Law and Justice.

3. To study the distribution of children lymphoid lesions in Vietnam and Taiwan and their virus association.

4. To establish a tissue bank for infectious diseases and lymphoma.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

Clinical diagnosis of infectious diseases and lymphoma.

Exclusion Criteria:

Study Design

Observational Model: Case Control, Time Perspective: Longitudinal

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Lymphoma

Locations

Country	Name	City	State
Taiwan	National Health Research Institutes	Zhunan Town, Miaoli County

Sponsors (1)

Lead Sponsor	Collaborator
National Health Research Institutes, Taiwan

Country where clinical trial is conducted

Taiwan,